{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T11:19:10Z","timestamp":1720523950348},"reference-count":119,"publisher":"Western Journal of Emergency Medicine","issue":"6","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WestJEM"],"DOI":"10.5811\/westjem.2020.8.48288","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T20:08:28Z","timestamp":1603138108000},"source":"Crossref","is-referenced-by-count":4,"title":["Emergency Department Management of COVID-19: An Evidence-Based Approach"],"prefix":"10.5811","volume":"21","author":[{"given":"Nicholas","family":"McManus","sequence":"first","affiliation":[{"name":"Mercy Health \u2013 Muskegon, Department of Emergency Medicine. Muskegon, Michigan; Michigan State University College of Osteopathic Medicine, Department of Osteopathic Medical Specialties, East Lansing, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Offman","sequence":"additional","affiliation":[{"name":"Mercy Health \u2013 Muskegon, Department of Emergency Medicine. Muskegon, Michigan; Michigan State University College of Osteopathic Medicine, Department of Osteopathic Medical Specialties, East Lansing, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Oetman","sequence":"additional","affiliation":[{"name":"Mercy Health \u2013 Muskegon, Department of Emergency Medicine. Muskegon, Michigan; Michigan State University College of Osteopathic Medicine, Department of Osteopathic Medical Specialties, East Lansing, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3840","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Chen Q, Allot A, Lu Z. Keep up with the latest coronavirus research. Nature. 2020;579(7798):193.","DOI":"10.1038\/d41586-020-00694-1"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bouadma L, Lescure F, Lucet J, et al. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020;46,579-582.","DOI":"10.1007\/s00134-020-05967-x"},{"key":"ref2","unstructured":"Mammon B. COVID-19 Prognostic tool. 2020. Available at: https:\/\/qxmd.com\/calculate\/calculator_731\/covid-19-prognostic-tool. Accessed April 30, 2020.\u00a0"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020;24,108.","DOI":"10.1186\/s13054-020-2833-7"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score. Front Microbiol. 2019;10:2752.","DOI":"10.3389\/fmicb.2019.02752"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Wallis LA. COVID-19 severity scoring tool for low resourced settings. Afr J Emerg Med. 2020;10(2):49.","DOI":"10.1016\/j.afjem.2020.06.001"},{"key":"ref6","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2020. Available at: http:\/\/www.covid19treatmentguidelines.nih.gov. Accessed April 30, 2020.\u00a0"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Wu Z and McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u201342.","DOI":"10.1001\/jama.2020.2648"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wang B, Li R, Lu Z, et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7), 6049\u201357.","DOI":"10.18632\/aging.103000"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9.","DOI":"10.3410\/f.737797860.793574198"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. In Press. 2020.","DOI":"10.1002\/dmrr.3319"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci and Technol. 2020;14(4):813-21.","DOI":"10.1177\/1932296820924469"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Cai Q, Chen F, Fang L, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7)1392-8.","DOI":"10.2337\/dci20-0034"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195-9.","DOI":"10.1002\/oby.23006"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020;71(15):896-7.","DOI":"10.1093\/cid\/ciaa415"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) \u2014 United States, February 12\u2013March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343-6.","DOI":"10.15585\/mmwr.mm6912e2"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Damiani G, Pacifico A, Bragazzi N, et al. Biologics increase the risk of SARS- CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE. Dermatol Ther. In Press. 2020.","DOI":"10.1111\/dth.13475"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wang K, Zuo P, Liu Y, et al. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China. Clin Infec Dis. In Press. 2020.","DOI":"10.2139\/ssrn.3546115"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Velavan T and Meyer C. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020 June;95:304-7.","DOI":"10.1016\/j.ijid.2020.04.061"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Forget P, Khalifa C, Defour J, et al. What is the normal value of the neutrophil-to-lymphocyte ratio?. BMC Res Notes. 2017;10(1):12.","DOI":"10.1186\/s13104-016-2335-5"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Xiao-ying Xia, Jing Wu, He-lei Liu, et al. Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19. J Clin Virol. 2020;127:104360.","DOI":"10.1016\/j.jcv.2020.104360"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Yang A, Liu J, Tao W, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.","DOI":"10.1016\/j.intimp.2020.106504"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-e12.","DOI":"10.1016\/j.jinf.2020.04.002"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395 (10229):1054-62.","DOI":"10.1016\/s0140-6736(20)30566-3"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7.","DOI":"10.1111\/jth.14768"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020 ;58(7):1116-1120.","DOI":"10.1515\/cclm-2020-0188"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;1-6.","DOI":"10.1002\/jmv.25770"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","DOI":"10.1001\/jama.2020.1585"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1-11.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lippi G, Favaloro E. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020;120(05):876-8.","DOI":"10.1055\/s-0040-1709650"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324-9.","DOI":"10.1111\/jth.14859"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Bi Z, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. Platelets. 2020;31(5):674-9.","DOI":"10.1080\/09537104.2020.1760230"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Zou Y, Guo H, Zhang Y, et al. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. BioScience Trends. In Press. 2020.","DOI":"10.5582\/bst.2020.03086"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Liu Y, Liao W, Wan L, et al. Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19.Viral Immunol. In Press. 2020.","DOI":"10.1089\/vim.2020.0062"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-9.","DOI":"10.1172\/JCI137244"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):1-10.","DOI":"10.1002\/jmv.25783"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1-12.","DOI":"10.1111\/all.14238"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Bikdeli B, Madhavan M, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. JACC. 2020;75(23):2950-73.","DOI":"10.1016\/j.jacc.2020.04.031"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20.","DOI":"10.1056\/NEJMoa2002032"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br Med J. 2020;368:m1091.","DOI":"10.1136\/bmj.m1091"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Yao Q, Wang P, Wang X, et al. Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients. Pol Arch Intern Med.2020;130:390-9.","DOI":"10.20452\/pamw.15312"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Wang F, Hou H, Luo Y, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020;5(10):e137799.","DOI":"10.1172\/jci.insight.137799"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8.","DOI":"10.1007\/s00134-020-05991-x"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 ;395(10223):507-13","DOI":"10.1016\/s0140-6736(20)30211-7"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74.","DOI":"10.1007\/s11427-020-1643-8"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann of the Rheum Dis. In Press. 2020.","DOI":"10.1136\/annrheumdis-2020-217573"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Rubin G, Ryerson C, Haramati L, et al. The role of chest imaging in patient management during the COVID-19 Pandemic: a multinational consensus statement from the Fleischner Society. Chest. 2020;158(1):106-16.","DOI":"10.1016\/j.chest.2020.04.003"},{"key":"ref48","unstructured":"ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. 2020. Available at: https:\/\/www.acr.org\/Advocacy-and-Economics\/ACR-Position-Statements\/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection. Accessed April 15, 2020."},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Fiala MJ. A brief review of lung ultrasonography in COVID-19: Is it useful? Ann Emerg Med. 2020 ;75(6):784-5.","DOI":"10.1016\/j.annemergmed.2020.03.033"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Peyrony O, Marbeuf-Gueye C, Truong V, et al. Accuracy of emergency department clinical findings for diagnosis of coronavirus disease 2019. Ann Emerg Med. In Press. 2020.","DOI":"10.1016\/j.annemergmed.2020.05.022"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Kanne P, Little B, Chung J, et al. Essentials for Radiologists on COVID-19: An Update\u2014Radiology Scientific Expert Panel. Radiology. 2020;296(2):E113-E114.","DOI":"10.1148\/radiol.2020200527"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Mayo H, Copetti R, Feller-Kopman D, et al. Thoracic ultrasonography: a narrative review. Intensive Care Med. 2019;45:1200-11.","DOI":"10.1007\/s00134-019-05725-8"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Peng Q, Wang X, Zhang L. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med. 2020;46:849-50.","DOI":"10.1007\/s00134-020-05996-6"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Smith M, Hayward S, Innes S, et al. Point-of-care lung ultrasound in patients with COVID-19 \u2013 a narrative review. Anaesthesia. 2020;75(8):1096-104.","DOI":"10.1111\/anae.15082"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Xing C, Li Q, Du H, et al. Lung ultrasound findings in patients with COVID-19 pneumonia.\u00a0Crit Care. 2020;24(1):174.","DOI":"10.1186\/s13054-020-02876-9"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Alhazzani W, Moller M, Arabi Y, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-87.","DOI":"10.1007\/s00134-020-06022-5"},{"key":"ref57","unstructured":"Lyness D, Anaethesia & Intensive Care, ESICM Editorial & Publishing Committee. Coronavirus - Public health emergency. 2020. Available at: https:\/\/www.esicm.org\/blog\/wp-content\/uploads\/2020\/03\/SSC-COVID19-.pdf. Accessed May 4, 2020."},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Meyhoff T, Moller M, Hjortrup P, et al. Lower versus higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis. Chest. 2020;157(6):1478-96.","DOI":"10.1016\/j.chest.2019.11.050"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Silversides J, Major E, Ferguson A, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43:155\u201370.","DOI":"10.1007\/s00134-016-4573-3"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Keddissi J, Youness H, Jones K, et al. Fluid management in acute respiratory distress syndrome: a narrative review. Can J Respir Ther. 2018;55:1-8.","DOI":"10.29390\/cjrt-2018-016"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Gamper G, Havel C, Arrich J, et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev. 2016;2(2):CD003709","DOI":"10.1002\/14651858.cd003709.pub3"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Rygard S, Butler E, Granholm A, et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44:1003\u201316.","DOI":"10.1007\/s00134-018-5197-6"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Lamontagne F, Rochwerg B, Lytvyn L, et al. Corticosteroid therapy for sepsis: a clinical practice guideline. Br Med J. 2018;362:k3284.","DOI":"10.1136\/bmj.k3284"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Tobin M. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med. 2020;201(11):1319-20.","DOI":"10.1164\/rccm.202004-1076ed"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099-102.","DOI":"10.1007\/s00134-020-06033-2"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Marini J, Gattinoni L. Management of COVID-19 respiratory distress. JAMA.\u00a02020;323(22):2329\u201330.","DOI":"10.1001\/jama.2020.6825"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection (\u200e\u200e\u200eSARI)\u200e\u200e\u200e when COVID-19 disease is suspected: interim guidance. 2020. Available at: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/clinical-management-of-novel-cov.pdf. Accessed access date.","DOI":"10.15557\/pimr.2020.0003"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Rochwerg B, Brochard L, Elliott M, et al. Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.","DOI":"10.1183\/13993003.02426-2016"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Arabi Y, Arifi A, Balkhy H, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389-97.","DOI":"10.7326\/m13-2486"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Bellani G, Laffey JG, Pham T, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am J Respir Crit Care Med. 2017;195(1):67-77.","DOI":"10.1164\/rccm.201606-1306oc"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Frat J, Thille A, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-96.","DOI":"10.1186\/2197-425x-3-s1-a425"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Wang K, Zhao W, Li J, et al. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care. 2020;10(1):37.","DOI":"10.1186\/s13613-020-00653-z"},{"key":"ref73","unstructured":"Australian and New Zealand Intensive Care Society. ANZICS COVID-19 Guidelines. 2020. Available at: https:\/\/www.anzics.com.au\/coronavirus-guidelines\/. Accessed access date."},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Gattinoni L, Coppola S, Cressoni M, et al. Covid-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome. AM J Respir Crit Care Med. 2020;201(10):1299-300.","DOI":"10.1164\/rccm.202003-0817le"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24(1):154.","DOI":"10.1186\/s13054-020-02880-z"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Denault A, Delisle S, Canty D, et al. A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failure. Can J Anesth. In Press. 2020.","DOI":"10.1007\/s12630-020-01704-6"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Bahl P, Doolan C, de Silva C, et al. Airborne or droplet precautions for health workers treating COVID-19? J Infect Dis. In Press. 2020.","DOI":"10.1093\/infdis\/jiaa189"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Van Doremalen N, Morris D, Holbrook M, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382:1564-7.","DOI":"10.1101\/2020.03.09.20033217"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Santarpia J, Rivera D, Herrera V, et al. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep. 2020;10:12732.","DOI":"10.1038\/s41598-020-69286-3"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Hui D, Chow B, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019;53(4)1802339.","DOI":"10.1183\/13993003.02339-2018"},{"key":"ref81","unstructured":"Leonard S, Volakis L.I., DeBellis R, et al. High velocity nasal insufflation (HVNI) therapy application in management of COVID-19. 2020. Available at: https:\/\/vapotherm.com\/blog\/transmission-assessment-report\/. Accessed April 15, 2020."},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020;55(5):2000892.","DOI":"10.1183\/13993003.00892-2020"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Whittle JS, Pavlov I, Sacchetti AD, et al. Respiratory support for adult patients with COVID-19. J Am Coll Emerg Physicians Open. 2020;1:95\u2013101.","DOI":"10.1002\/emp2.12071"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98.","DOI":"10.1007\/s00134-020-06062-x"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-4.","DOI":"10.1111\/jth.14830"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Middeldorp S, Coppens M, van Haaps T.F, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995-2002.","DOI":"10.1111\/jth.14888"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Klok F, Kruip M, van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. In Press. 2020.","DOI":"10.1016\/j.thromres.2020.04.041"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Lodigiania C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14.","DOI":"10.1016\/j.thromres.2020.04.024"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Llitjos J, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. In Press. 2020.","DOI":"10.1111\/jth.14869"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Demelo-Rodr\u00edguez P, Cervilla-Mu\u00f1oz E, Ordieres-Ortega L, et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23-6.","DOI":"10.1016\/j.thromres.2020.05.018"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Tal S, Spectre G, Kornowski R, et al. Venous thromboembolism complicated with COVID-19: What do we know so far? Acta Haematol. In Press. 2020.","DOI":"10.1159\/000508233"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? [published correction appears in Lancet Respir Med. 2020;8(6):e54.","DOI":"10.1016\/s2213-2600(20)30116-8"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"World Health Organization. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. 2020. Available at: https:\/\/www.who.int\/news-room\/commentaries\/detail\/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19. Accessed April 30, 2020.","DOI":"10.15557\/pimr.2020.0022"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Lee N, Allen Chan K, Hui D, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol. 2004;31(4):304-9.","DOI":"10.1016\/j.jcv.2004.07.006"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Lee D, Wing Y, Leung H, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis. 2004;39(8):1247-9.","DOI":"10.1086\/424016"},{"key":"ref96","unstructured":"Xiao JZ, Ma L, Gao J, et al. Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Nei Ke Za Zhi. 2004;43(3):179-82."},{"key":"ref97","unstructured":"Li YM, Wang SX, Gao HS, et al. Factors of avascular necrosis of femoral head and osteoporosis in SARS patients\u2019 convalescence. Zhonghua Yi Xue Za Zhi. 2004;84(16):1348-53."},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Sung JJ, Wu A, Joynt GM, et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax. 2004;59(5):414-20.\u00a0","DOI":"10.1136\/thx.2003.014076"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Fang X, Mei Q, Yang T, et al. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19. J Infect. 2020;81(1):147-78.","DOI":"10.1016\/j.jinf.2020.03.039"},{"key":"ref100","unstructured":"Long Y, Xu Y, Wang B, et al. Clinical recommendations from an observational study on MERS: glucocorticoids was benefit in treating SARS patients. Int J Clin Exp Med. 2016;9(5):8865-73."},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Weigelt JA, Norcross JF, Borman KR, et al. Early steroid therapy for respiratory failure. Arch Surg. 1985;120(5):536\u201340.","DOI":"10.1001\/archsurg.1985.01390290018003"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Bernard G, Luce J, Sprung C, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317(25):1565-70.","DOI":"10.1056\/NEJM198712173172504"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled Trial. JAMA. 1998;280(2):159\u201365.","DOI":"10.1001\/jama.280.2.159"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Wang Y, Jiang W, He Q, et al. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China. medRxiv. In Press. 2020.","DOI":"10.1101\/2020.03.06.20032342"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Ye Z, Wang Y, Prasad M, et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ. 2020;192(27):E756-E767.","DOI":"10.1503\/cmaj.200645"},{"key":"ref106","unstructured":"Bhimraj A, Morgan RL, Hirsch Shumaker A, et al. Infectious Disease Society of America Guidelines on the Treatment and Management of Patients with COVID-19. 2020. Available at: https:\/\/www.idsociety.org\/Accessed August 13, 2020."},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Rawson T, Moore L, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. In Press. 2020.","DOI":"10.1093\/cid\/ciaa530"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Damle B, Vourvahis M, Wang E, et al. Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19. Clin Pharmacol Ther. 2020;108(2):201-11.","DOI":"10.1002\/cpt.1857"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Conforti C, Giuffrida R, Zalaudek I, et al. Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak. Dermatol Ther. In Press. 2020.","DOI":"10.1111\/dth.13437"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Ignarro, LJ. Inhaled NO and COVID-19. Br J Pharmacol. 2020;177(16):3848-9.","DOI":"10.1111\/bph.15085"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Chen L, Liu P, Gao H, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis. 2004;39(10):1531-5.","DOI":"10.1086\/425357"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Mourad J and Levy BI. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Nat Rev Cardiol. In Press. 2020.","DOI":"10.1038\/s41569-020-0368-x"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Mancia G, Rea F, Ludergnani M, et al. Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382:2431-40.","DOI":"10.1056\/nejmoa2006923"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Reynolds H, Adhikari S, Pulgarin C, et al. Renin\u2013angiotensin\u2013aldosterone system inhibitors and the Risk of Covid-19. N Engl J Med. 2020;382:2441-8.","DOI":"10.1056\/NEJMoa2008975"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Bozkurt B, Kovacs R, Harrington B. HFSA\/ACC\/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020;26(5):370.","DOI":"10.1016\/j.cardfail.2020.04.013"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Glatthaar-Saalm\u00fcller B, Mair K, Saalmueller A. Antiviral activity of aspirin against RNA viruses of the respiratory tract - an in vitro study. Influenza Other Respir Viruses. 2017;11(1):85-92.","DOI":"10.1111\/irv.12421"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Speir E, Yu Z, Ferrans V, et al. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res. 1998;83:210-6.","DOI":"10.1161\/01.res.83.2.210"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Amici C, Di Caro A, Ciucci A, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11:1021-30.","DOI":"10.1177\/135965350601100803"}],"container-title":["Western Journal of Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T22:48:58Z","timestamp":1669243738000},"score":1,"resource":{"primary":{"URL":"https:\/\/escholarship.org\/uc\/item\/4f96w6xg"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":119,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.5811\/westjem.2020.8.48288","relation":{},"ISSN":["1936-900X"],"issn-type":[{"value":"1936-900X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,25]]}}}